CSPPT相关论文

  1. Wang X, Demirtas H, Xu X. Homocysteine, B vitamins, and cardiovascular disease. N Engl J Med. 2006 Jul 13; 355(2): 207-9; author reply 209-11. (IF: 70.67)
  2. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007; 369:1876-1882. (IF: 59.102) (Faculty of 1000 medicine)
  3. Wang X, Qin X, Demirtas H. Folic acid for stroke prevention. Lancet. 2007; 370:651. (IF: 59.102)
  4. Mao G, Hong X, Xing H, Liu P, Liu H, Yu Y, Zhang S, Jiang S, Wang X, Xu X. Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: a multicenter, randomized, double-blind, parallel-controlled, clinical trial. Nutrition. 2008; 24:1088-96. (IF: 3.591)
  5. Fan FF, Huo Y, Wang X, Xu X, Wang BY, Xu XP, Li JP. Effect of enalapril on plasma homocysteine levels in patients with essential hypertension. J Zhejiang Univ Sci B. 2010 ;11:583-91. (IF: 1.879)
  6. Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D, Xu X, Wang X. Folic acid therapy and cardiovascular disease in ESRD or Advanced Chronic Kidney Disease: A Meta-Analysis. Clin J Am Soc Nephrol 2011; 6:482-488. (IF: 6.243)
  7. Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, Xu X, Wang X, Xu X, Huo Y. Effect of folic acid intervention on ALT concentration in hypertensives without known hepatic disease: a randomized, double-blind, controlled trial. Eur J Clin Nut 2012; 66: 541-548. (IF: 3.114)
  8. Huo Y*, Qin X*, Wang J, Sun N, Zeng Q, Xu X, Liu L, Xu X, Wang X. Efficacy of Folic Acid Supplementation in Stroke Prevention: New Insight from a Meta-analysis. Int J Clin Pract 2012; 66: 544-551. (IF: 2.613)
  9. Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, Xu X, Wang X, Xu X, Huo Y. MTHFR C677T and MTR A2756G Polymorphisms and the Homocysteine Lowering Efficacy of Different Doses of Folic Acid in Hypertensives Chinese Adults. Nutr J. 2012; 11:2. (IF: 3.592)
  10. Qin X, Xu M, Zhang Y, Li J, Xu X, Wang X, Xu X, Huo Y. Effect of Folic Acid Supplementation on the Progression of Carotid Intima-Media Thickness: A Meta-Analysis of Randomized Controlled Trials. Atherosclerosis.2012; 222: 307-313. (IF:4.255)
  11. Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, Xu X, Wang X, Xu X, Huo Y. Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses? Pharmacogenet Genomics. 2012; 22:421-428. (IF: 2.693)
  12. He M*, Qin X*, Cui Y, Cai Y, Sun L, Xu X, Wang B, Tang G, Xing H, Wang X, Xu X, Huo Y. Unrecognized lower extremity peripheral arterial disease prevalence and the associated factors in Chinese hypertensive adults. Am J Cardiol 2012; 110: 1692-1698. (IF: 2.843)
  13. Wang Y, Li X, Qin X, Cai Y, He M, Sun L, Li J, Zhang Y, Tang G, Wang B, Sun N, Xu X, Liu L, Xu X, Huo Y. Prevalence of hyperhomocysteinemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years. Br J Nutr. 2013; 109:1284-1293. (IF: 3.319)
  14. Qin X, Li J, Zhang Y, Ma W, Fan F, Wang B, Xing H, Tang G, Wang X, Xu X, Xu X, Huo Y. Prevalence and associated factors of diabetes and impaired fasting glucose in Chinese hypertensive adults aged 45 to 75 years. PLoS ONE 2012; 7(8): e42538. (IF: 2.776)
  15. Zhang Y*, Qin X*, Li JP, Cui YM, Liu ZY, Zhao ZG, Ge JB, Guan DM, Hu J, Wang YN, Zhang FM, Xu X, Xu XP, Huo Y. Factors Underlying the Association of Body Mass Index with Serum ALT in Chinese Hypertensive Adults without Known Hepatic Diseases. J Zhejiang Univ Sci B. 2013; 14: 743-748. (IF: 1.879)
  16. Qin X, Cui Y, Shen L, Sun N, Zhang Y, Li J, Xu X, Wang B, Xu X, Huo Y, Wang X. Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials. Int J Cancer. 2013; 133:1033-1041. (IF: 4.982)
  17. Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trials. Clin Nutr. 2013; 32:722-727. (IF: 6.402) (Faculty of 1000 medicine)
  18. Qin X, Zhang Y, Cai Y, He M, Sun L, Fu J, Li J, Wang B, Xing H, Tang G, Wang X, Xu X, Xu X, Huo Y. Prevalence of obesity, abdominal obesity and associated factors in hypertensive adults aged 45 to 75 years. Clin Nutr. 2013; 32: 361-367. (IF: 6.402)
  19. Qin X, Fan F, Cui Y, Chen F, Chen Y, Cheng X, Li Y, Wang B, Xu X, Xu X, Huo Y, Wang X. Folic acid supplementation with and without vitamin B6 and revascularization risk: A meta-analysis of randomized controlled trials. Clin Nutr. 2014; 33:603-12. (IF: 6.402)
  20. Zheng M, Xu X, Wang X, Huo Y, Xu X, Qin X, Tang G, Xing H, Fan F, Cui W, Yang X. Age, arterial stiffness, and components of blood pressure in Chinese adults. Medicine. 2014; 93:e262. (IF: 1.87)
  21. Li H#, Qin X, Xie D, Tang G, Zhang Y, Li J, Hou FF, Wang X, Huo Y, Xu XP*. Effects of combined enalapril and folic acid therapy on the serum uric acid levels in hypertensive patients: a multicenter, randomized,double-blind, parallel-controlled clinical trial. Intern Med 2015; 54:17-24. (IF: 0.956)
  22. Xie D#, Yuan Y, Guo JN, Yang SL, Xu X, Wang Q, Li Y, Qin X, Tang G, Huo Y, Deng G, Wu S, Wang B, Zhang Q, Wang X, Fang P, Wang H, Xu XP, Hou FF*. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults. Scientific Reports 2015; 5:16268. (IF: 4.122)
  23. Zheng M#, Huo Y*, Wang X, Xu XP, Qin X, Tang G, Xing H, Fan F, Li J, Zhang Y, Wang B, Xu X, Yang X*, Chen Y, Qian G. A prospective study on pulse wave velocity (PWV) and response to anti-hypertensive treatments: PWV determines BP control. Int J Cardiol 2015; 178:226-31. (IF: 3.471)
  24. Huo Y#*, Li J, Qin X, Huang Y, Wang X, Gottesman RF, Tang G, Wang B, Chen D, He M, Fu J, Cai Y, Shi X, Zhang Y, Cui Y, Sun N, Li X, Cheng X, Wang J, Yang X, Yang T, Xiao C, Zhao G, Dong Q, Zhu D, Wang X, Ge J, Zhao L, Hu D, Liu L, Hou FF*; CSPPT Investigators. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 2015; 313:1325-35. (IF: 51.273) (Faculty of 1000 medicine)
  25. Xie H#, Zhang C*, Wang Y, Huang S, Cui W, Yang W, Koski L, Xu X, Li Y, Zheng M, He M, Fu J, Shi X, Wang K, Tang G, Wang B, Huo Y*. Distinct Patterns of Cognitive Aging Modified by Education Level and Gender among Adults with Limited or No Formal Education: A Normative Study of the Mini-Mental State Examination. J Alzheimers Dis 2015; 49:961-9. (IF: 3.517)
  26. Zhang C#, Wang X, He M, Qin X, Tang G, Xu X, Wang Y, Huo Y, Cai Y, Fu J, Zhao G, Dong Q, Xu X, Wang B*, Hou F*. Proteinuria is an independent risk factor for first incident stroke in adults under treatment for hypertension in China. Journal of the American Heart Association 2015; 4(12). (IF: 4.66)
  27. Qian G#, Zeng LH, Liu YQ, Cao F, Chen YD*, Zheng ML, Yang XC, Xu XP, Huo Y. Associations between plasma total homocysteine, blood pressure stages and pulse wave velocity in Chinese rural community population. Blood Press. 2015 Dec;24(6):340-6. (IF: 2.292)
  28. Wei R#, Liu LS, Wang LW, Li YB, Zhang T, Liu J, Zuo SW, Jia SH, Song YX, Wu ZY, Duan C, Ge YY, Li HB, Xiong J, Jia X, Wang X, Kong W, Xu XP, Guo W*, Huo Y*. Association of Resting Heart Rate with Infrarenal Aortic Diameter: A Cross Sectional Study in Chinese Hypertensive Adults. Eur J Vasc Endovasc Surg. 2015 Dec;50(6):714-21. (IF: 3.642)
  29. Liu X#, Sun N*, Yu T, Fan F, Zheng M, Qian G, Wang B, Wang Y, Tang G, Li J, Qin X, Hou F, Xu X, Yang X, Chen Y, Wang X, Huo Y. The Independent and Joint Association of Blood Pressure, Serum Total Homocysteine, and Fasting Serum Glucose Levels With Brachial-Ankle Pulse Wave Velocity in Chinese Hypertensive Adults. Int Heart J 2016; 57:627-33. (IF: 2.226)
  30. Wei Yang#, Yong Huo*, et al. Association between Body Mass Index and All-Cause Mortality in Hypertensive Adults: Results from the China Stroke Primary Prevention Trial (CSPPT). Nutrients 2016, 8, 384. (IF: 4.171)
  31. Song Y#, Xu B, Xu R, Tung R, Frank E, Tromble W, Fu T, Zhang W, Yu T, Zhang C, Fan F, Zhang Y, Li J, Bao H, Cheng X, Qin X, Tang G, Chen Y, Yang T, Sun N, Li X, Zhao L, Hou FF, Ge J, Dong Q, Wang B, Xu X*, Huo Y*. Independent and Joint Effect of Brachial-Ankle Pulse Wave Velocity and Blood Pressure Control on Incident Stroke in Hypertensive Adults. Hypertension 2016; 68:46-53. (IF: 7.017)
  32. Qin X#, Shen L, Zhang R, Li Y, Wang X, Wang B, Jiang X, Jiang H, Lei Y, Hou FF, Gu J*, Huo Y*. Effect of folic acid supplementation on cancer risk among adults with hypertension in China: A randomized clinical trial. Int J Cancer. 2017 Aug 15;141(4):837-847. (IF: 4.982)
  33. Qin X#, Li J, Zhang Y, Chen D, Wang B, He M, Fu J, Tang G, Cai Y, Shi X, Xu X, Hou FF, Wang X, Huo Y*. Effect of folic acid supplementation on risk of new-onset diabetes in adults with hypertension in China: Findings from the CSPPT. J Diabetes 2016; 8: 286-294. (IF: 3.298)
  34. Qin X#, Huo Y*. H-type hypertension, stroke and diabetes in China: Opportunities for primary prevention. J Diabetes 2016; 8: 38-40. (IF: 3.298)
  35. Qin X#, Li J#, Spence JD, Zhang Y, Li Y, Wang X, Wang B, Sun N, Chen F, Guo J, Yin D, Sun L, Tang G, He M, Fu J, Cai Y, Shi X, Ye P, Chen H, Zhao S, Chen M, Gao C, Kong X, Hou FF, Huang Y*, Huo Y*. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients. Stroke. 2016 Nov; 47(11):2805-2812. (IF: 6.046)
  36. Xu X#, Qin X#, Li Y, Sun D, Wang J, Liang M, Wang B, Huo Y, Hou FF*; investigators of the Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT). Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial. JAMA Intern Med. 2016;176(10):1443-1450. (IF: 20.768)
  37. Qin X#, Li Y#, Sun N, Wang H, Zhang Y, Wang J, Li J, Xu X, Liang M, Nie J, Wang B, Cheng X, Li N, Sun Y, Zhao L, Wang X, Hou FF*, Huo Y*. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients. Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):166-172. （IF: 6.618）
  38. Liu Y, Kong X, Wang W, Fan F, Zhang Y, Zhao M, Wang Y, Wang Y, Wang Y, Qin X, Tang G, Wang B, Xu X, Hou FF, Gao W, Sun N, Li J, Venners SA, Jiang S, Huo Y. Association of Peripheral Differential Leukocyte Counts with Dyslipidemia Risk in Chinese Patients with Hypertension: Insight from the CSPPT. J Lipid Res. 2017 Jan;58(1):256-266. （IF: 4.743）
  39. Qin X, Li Y, He M, Tang G, Yin D, Liang M, Wang B, Nie J, Huo Y, Xu X, Hou FF. Folic acid therapy reduces serum uric acid in hypertensive patients: a sub-study of the China Stroke Primary Prevention Trial (CSPPT). Am J Clin Nutr. 2017 Apr;105(4):882-889. (IF: 6.568)
  40. Xu RB, Kong X, Xu BP, Song Y, Ji M, Zhao M, Huang X, Li P, Cheng X, Chen F, Zhang Y, Tang G, Qin X, Wang B, Hou FF, Dong Q, Chen Y, Yang T, Sun N, Li X, Zhao L, Ge J, Ji L, Huo Y, Li J. Longitudinal Association between Fasting Blood Glucose Levels and First Stroke among Hypertensive Adults in China: Effect of Folic Acid Intervention. Am J Clin Nutr.2017 Mar;105(3):564-570. (IF: 6.568)
  41. Xu B, Kong X, Xu R, Song Y, Liu L, Zhou Z, Gu R, Shi X, Zhao M, Huang X, He M, Fu J, Cai Y, Li P, Cheng X, Wu C, Chen F, Zhang Y, Tang G, Qin X, Wang B, Xue H, Chen Y, Tian Y, Sun N, Cui Y, Hou FF, Li J, Huo Y. Homocysteine and All-Cause Mortality in Hypertensive Adults without Pre-existing Cardiovascular Conditions: Effect Modification by MTHFR C677T Polymorphism. Medicine. 2017 Feb;96(8):e5862. (IF= 1.87)
  42. Fan F, Yuan Z, Qin X, Li J, Zhang Y, Li Y, Yu T, Ji M, Ge J, Zheng M, Yang X, Bao H, Cheng X, Gu D, Zhao D, Wang J, Sun N, Chen Y, Wang H, Wang X, Parati G, Hou F, Xu X, Wang X, Zhao G, Huo Y. Optimal systolic blood pressure levels for primary prevention of stroke in general hypertensive adults: findings from the China Stroke Primary Prevention Trial (CSPPT). Hypertension. 2017 Apr;69(4):697-704. (IF: 7.017)
  43. Qin X, Li Y, Sun N, He M, Tang G, Yin D, Wang J, Liang M, Wang B, Huo Y, Xu X, Xu X, Hou FF. Impact of achieved blood pressure on first stroke in uncomplicated grade 1 hypertension. J Am Heart Assoc. 2017 Mar 8;6(3) (IF: 4.66)
  44. Men X#, Sun W, Fan F, Zhao M, Huang X, Wang Y, Liu L, Liu R, Qin X, Tang G, Li J, Zhang Y, Cai Y, Hou F, Xu X, Wang B, Cheng X, Sun N, Huang Y, Huo Y. China Stroke Primary Prevention Trial (CSPPT): Visit-to-visit systolic blood pressure variability is an independent predictor of primary stroke in hypertensive patients. Journal of the American Heart Association. 2017 Mar 13;6(3). (IF: 4.66)
  45. Zhao M, Wang X, He M, Qin X, Tang G, Huo Y, Li J, Fu J, Huang X, Cheng X, Wang B, Hou FF, Sun N, Cai Y. Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention. Stroke. 2017 May;48(5):1183-1190. ( IF: 6.046)
  46. Bao H, Cai H, Zhao Y, Huang X, Fan F, Zhang C, Li J, Chen J, Hong K, Li P, Wu Y, Wu Q, Wang B, Xu X, Li Y, Huo Y, Cheng X. Nonspecific ST-T changes associated with unsatisfactory blood pressure control among adults with hypertension in China: Evidence from the CSPPT study. Medicine. Mar; 96(13):e6423. (IF: 1.87)
  47. Zhao M, Wu G, Li Y, Wang X, Hou FF, Xu X, Qin X, Cai Y. Meta-analysis of folic acid efficacy trials in stroke prevention: Insight into effect modifiers. Neurology. 2017 May 9;88(19):1830-1838. (IF: 8.689)
  48. Yang J, Wang Y, Zhao Q, Zhang X, Wang X, Qin X, Zhang R, Shen L, Jiang X, Jiang H, Lei Y, Wang B, Gu J, Hou FF, Huo Y, Gao W, Xu X. Association of Serum Uric Acid with Increased Risk of Cancer among Hypertensive Chinese. Int J Cancer.2017 141(1):112-120 (IF: 4.982)
  49. Li Y, Qin X, Luo L, Wang B, Huo Y, Hou FF, Xu X. Folic acid therapy reduces the risk of mortality associated with heavy proteinuria among hypertensive patients. Journal of Hypertension.2017 Jun;35(6):1302-1309. (IF: 4.209)
  50. Chen X, Meng Y, Li J, She H, Zhao L, Zhang J, Peng Y, Shang K, Zhang Y, Gu X, Yang W, Zhang Y, Li J, Qin X, Wang B, Xu X, Hou F, Tang G, Liao R, Huo Y, Yang L. Serum uric acid concentration is associated with hypertensive retinopathy in hypertensive chinese adults. BMC ophthalmology. 2017. Jun 2;17(1):83. (IF: 1.431)
  51. Shi X, Yang J, Wang L, Zhao M, Zhang C, He M, Qin X, Tang G, Li J, Zhang Y, Huo Y, Cai Y, Zhao G, Dong Q, Xu X, Wang B, Fu J, Wang K. Prospective study of serum uric acid levels and stroke in a Chinese hypertensive cohort. Clin Exp Hypertens. 2017 Jun 1:1-5. (IF: 1.522)
  52. Momin M, Li JP, Zhang Y, Fan FF, Xu XP, Xu X, Wang BY, Yang WB, Xie LL, Huo Y. Body mass index is inversely associated with arterial stiffness in Chinese adults with primary hypertension: results from the China Stroke Primary Prevention Trial (CSPPT). Clin Exp Hypertens. 2017 May 23:1-8. (IF: 1.522)
  53. Li Y, Li Y, Liang M, Wang G, Wang B, He M, Tang G, Yin D, Xu X, Huo Y, Cui Y, Hou FF, Qin X. Effects of Folic Acid Therapy on the New-Onset Proteinuria in Chinese Hypertensive Patients A Post Hoc Analysis of the Renal Substudy of CSPPT. Hypertension. 2017 Jun 12. (IF: 7.017)
  54. Wang Y, Zhong B, Li Y, Qin X, Wang B, Xu X, Hou F, Huo Y, Xu X. Relationship of diabetes with renal dysfunction in hypertensive adults. Medicine. 2017 Jun;96(24):e7169. (IF: 1.87)
  55. Li L, Li P, Yang J, Huang X, Bao H, Zhang C, Song Y, Zhao M, Ji M, Wang Y, Qian G, Tang G, Jiang S, Dong Q, Zhang Y, Li J, Xu X, Wang B, Huo Y, Cheng X. Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial. Sci Rep. 2017 Aug 1;7(1):7014. (IF: 4.011)
  56. Zhang J, Tang G, Xie H, Wang B, He M, Fu J, Shi X, Zhang C, Huo Y, Xu X, Wang K. Higher Adiposity is Associated with Slower Cognitive Decline in Hypertensive Patients: Secondary Analysis of the China Stroke Primary Prevention Trial. J Am Heart Assoc. 2017 Oct 10;6(10) (IF: 4.66)
  57. Huang X, Li Y, Li P, Li J, Bao H, Zhang Y, Wang B, Sun N, Wang J, He M, Yin D, Tang G, Chen Y, Cui Y, Huang Y, Hou FF, Qin X, Huo Y, Cheng X. Association between percent decline in serum total homocysteine and risk of first stroke. Neurology. 2017 Nov 14;89(20):2101-2107. ( IF: 8.689)
  58. Li Y, Liang M, Jiang C, Wang G, Li J, Zhang Y, Fan F, Sun N, Cui Y, He M, Tang G, Yin D, Cheng X, Wang B, Huo Y, Xu X, Hou FF, Xu X, Qin X. Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney disease. Nephrol Dial Transplant. 2017. 32: 1–9. （IF: 4.198）
  59. Zhou Z, Li J, Yu Y, Li Y, Zhang Y, Liu L, Song Y, Zhao M, Wang Y, Tang G, He M, Xu X, Cai Y, Dong Q, Yin D, Huang X, Cheng X, Wang B, Hou FF, Wang X, Qin X, Huo Y. Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive Men. Stroke. 2018 Jan;49(1):114-120. (IF: 6.046)
  60. Huang X, Qin X, Yang W, Liu L, Jiang C, Zhang X, Jiang S, Bao H, Su H, Li P, He M, Song Y, Zhao M, Yin D, Wang Y, Zhang Y, Li J, Yang R, Wu Y, Hong K, Wu Q, Chen Y, Sun N, Li X, Tang G, Wang B, Cai Y, Hou FF, Huo Y, Wang H, Wang X, Cheng X. MTHFR Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment. Arterioscler Thromb Vasc Biol. 2018 Jan 25. (IF: 6.618)
  61. Wang J, Wang B, Liang M, Wang G, Li J, Zhang Y, Huo Y, Cui Y, Xu X, Qin X. Independent and combined effect of bilirubin and smoking on the progression of chronic kidney disease. Clin Epidemiol. 2018 Jan 15;10:121-132. (IF: 3.178)
  62. Chen L, Wang B, Wang J, Ban Q, Wu H, Song Y, Zhang J, Cao J, Zhou Z, Liu L, Cao T, Gao L, Guo H, Zhang T, Tang G, Huang X, Zhang Y, Li J, Huo Y, Cheng X, Zang T, Xu X, Zhang H, Qin X. Association between serum total homocysteine and arterial stiffness in adults: a community-based study. J Clin Hypertens (Greenwich). 2018 Apr;20(4):686-693. (IF: 2.444）
  63. Wang J, Ouyang N, Qu L, Lin T, Zhang X, Yu Y, Jiang C, Xie L, Wang L, Wang Z, Ren S, Chen S, Huang J, Liu F, Huang W, Qin X. Effect of MTHFR A1298C and MTRR A66G Genetic Mutations on Homocysteine Levels in the Chinese Population: A Systematic Review and Meta-analysis. J Transl Int Med. 2017 Dec 29;5(4):220-229.
  64. Liu J, Jia X, Jia S, Qin X, Zhang T, Liu L, Li H, Rong D, Zhou Z, Song Y, Zuo S, Duan C, Wu Z, Wei R, Ge Y, Wang X, Kong W, Xu X, Khalil RA, Huo Y, Guo W. Small infrarenal aortic diameter associated with lower-extremity peripheral artery disease in Chinese hypertensive adults. Sci Rep. 2017 Nov 6;7(1):14547. (IF: 4.011)
  65. Kong X, Xiao Huang, Min Zhao, et, al. Platelet Count Affects Efficacy of Folic Acid in Preventing First Stroke: Findings from CSPPT. J Am Coll Cardiol. May 15, 2018, 71 (19) 2136-2146. (IF: 18.639)
  66. Wu H, Wang B, Ban Q, Chen L, Yan D, Yu Y, Song Y, Liu C, Cao J, Zhang J, Zhang Y, Zhang T, Zhang H, Guo H, Tang G, Zhang Y, Li J, Huo Y, Zang T, Qin X, Xu X. Association of total homocysteine with blood pressure in a general population of Chinese adults: a cross-sectional study in Jiangsu province, China. BMJ Open. 2018 Jun 19;8(6):e021103. (IF: 2.376)
  67. Xie L, Wang B, Jiang C, Zhang X, Song Y, Li Y, Wang J, Yu Y, Liang M, Wang G, Zhang Y, Li J, Huo Y, Xu X, Nie J, Qin X. BMI is associated with the development of chronic kidney diseases in hypertensive patients with normal renal function. J Hypertens. 2018 Oct;36(10):2085-2091. (IF: 4.209)
  68. Nie J, Xie L, Zhao BX, Li Y, Qiu B, Zhu F, Li GF, He M, Wang Y, Wang B, Liu S, Zhang H, Guo H, Cai Y, Huo Y, Hou FF, Xu X, Qin X. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients. Stroke. 2018;49:2021-2028.(IF: 6.046)
  69. Yang X, Zhang M, Song R, Liu C, Huo Y, Qian G.The modifying effect of the MTHFR genotype on the association of folic acid supplementation and pulse wave velocity: findings from the CSPPT. Cardiovasc Ther. 2018 Oct 29:e12473.(IF: 2.315)
  70. Meng Y, Li J, Chen X, She H, Zhao L, Peng Y, Zhang J, Shang K, Li H, Yang W, Zhang Y, Gu X, Li J, Qin X, Wang B, Xu X, Hou F, Tang G, Liao R, Yang L, Huo Y. Association Between Folic Acid Supplementation and Retinal Atherosclerosis in Chinese Adults With Hypertension Complicated by Diabetes Mellitus.Front Pharmacol. 2018 Oct 30;9:1159.(IF: 3.845)
  71. Wang Z, Zhang C, Bao H, Huang X, Fan F, Zhao Y, Li J, Chen J, Hong K, Li P, Wu Y, Wu Q, Wang B, Xu X, Li Y, Huo Y, Cheng X. Value of electrocardiographic left ventricular hypertrophy as a predictor of poor blood pressure control: Evidence from the China stroke primary prevention trial. Medicine . 2018 Nov;97(44):e12966. (IF: 1.87)
  72. Wang B, Wu H, Li Y, Ban Q, Huang X, Chen L, Li J, Zhang Y, Cui Y, He M, Tang G, Yin D, Li J, Huo Y, Qin X, Xu X. Effect of long-term low-dose folic acid supplementation on degree of total homocysteine-lowering: major effect modifiers. Br J Nutr. 2018. Nov;120(10):1122-1130. (IF: 3.319)
  73. Yu Y, Zhang H, Song Y, Lin T, Zhou Z, Guo H, Liu L, Wang B, Liu C, Li J, Zhang Y, Huo Y, Wang G, Wang X, Hou FF, Qin X, Xu X. Plasma retinol and the risk of first stroke in hypertensive adults: a nested case-control study. Am J Clin Nutr. 2019 Jan 9. (IF: 6.568)
  74. Lin T, el al. Plasma 25-Hydroxyvitamin D concentrations and risk of incident cancer in adults with hypertension: A nested case control study. Clin Nutr. 2018 Nov 5. (IF: 6.402)
  75. Jiancheng Wang, Huiyuan Guo, Tengfei Lin, et al. A Nested Case-Control Study on Plasma Vitamin E and Risk of Cancer: Evidence of Effect Modication by Selenium. J Acad Nutr Diet. 2019 Jan 31. (IF: 4.141)
  76. Jiang C,Wang B,Li Y,Xie L,Zhang X,Wang J,Yu Y,Song Y,Liang M,Wang G,Li J,Zhang Y,Liu L,Liu C,Tang G,Huo Y. U-shaped association between serum albumin and development of chronic kidney disease in general hypertensive patients. Clin Nutr.2019 Feb 14. (IF: 6.402)
  77. Zhao Y,Huang X,Zhang PP,Bao H,Yu Y,Zhao M,Gu R,Li W,Wang J,Xu QF,Fan F,Li J,Zhang Y,Wang Y,Tang G,Cai Y. Electrocardiographic-left ventricular hypertrophy and incident stroke among Chinese hypertensive adults. J Hum Hypertens.2019 Jan 10. (IF: 1.935)
  78. Zhang X,Wang B,Yang J,Wang J,Yu Y,Jiang C,Xie L,Song Y,Zhong B,Li Y,Liang M,Wang G,Li J,Zhang Y,Huo Y. Serum lipids and risk of rapid renal function decline in treated hypertensive adults with normal renal function. Am J Hypertens.2019 Mar 16. (IF: 2.53)
  79. Zhan B, Huang X, Wang J, Qin X, Zhang J, Cao J, Song Y, Liu L, Li P, Yang R, Wu Y, Wu Q, Zhang Y, Li J, Huo Y, Wang B, Xu X, Bao H, Cheng X. Association Between Lipid Profiles and Arterial Stiffness in Chinese Patients With Hypertension: Insights From the CSPPT. Angiology. 2019 Jul. (IF: 2.376)
  80. Cao J, Zhang J, Li Q, Jiang C, Song Y, Liu C, Liu L, Wang B, Li J, Zhang Y, Cui Y, Huo Y, Wang X, Tang G, Xu X, Qin X. Serum Phosphate and the Risk of New-Onset Hyperuricemia in Hypertensive Patients. Hypertension. 2019 Jul. (IF: 7.017)
  81. Li Y, Li D, Song Y, Gao L, Fan F, Wang B, Liang M, Wang G, Li J, Zhang Y, Xu X, Hou FF, Cheng X, Sun N, Sun Y, Zhao L, Wan Q, Li X, Li J, Han Q, Xu X, Huo Y, Qin X. Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patients. Nephrol Dial Transplant. 2019 May 18. (IF:4.198)
  82. Hu L, Zhang Y, Huang X, Song Y, Qin X, Wang B, Zhang Y, Tang G, Li J, Li P, Bao H, Huo Y, Cheng X. Associations between Blood Pressure Indices and Brachial-ankle Pulse Wave Velocity in Treated Hypertensive Adults: results from the China Stroke Primary Prevention Trial (CSPPT). Sci Rep. 2019 Jun 3. (IF:4.011)
  83. Zhang J, Cao J, Zhang H, Jiang C, Lin T, Zhou Z, Song Y, Li Y, Liu C, Liu L, Wang B, Tang G, Li J, Zhang Y, Cui Y, Huo Y, Yang Y, Ling W, Yang J, Guo H, Wang X, Xu X, Qin X. Plasma copper and the risk of first stroke in hypertensive patients: a nested case-control study. Am J Clin Nutr. 2019 Jun 4 (IF:6.568)
  84. Xie L, Song Y, Lin T, Guo H, Wang B, Tang G, Liu C, Huang W, Yang Y, Ling W, Zhang Y, Li J, Huo Y, Wang X, Zhang H, Qin X, Xu X. Association of plasma retinol levels with incident cancer risk in Chinese hypertensive adults: a nested case-control study. Br J Nutr. 2019 Aug 14. (IF:3.319)
  85. Zhang Y, Li H, Lin T, Guo H, Jiang C, Xie L, Li Y, Zhou Z, Song Y, Wang B, Liu C, Liu L, Li J, Zhang Y, Wang G, Liang M, Cui Y, Huo Y, Yang Y, Ling W, Yang J, Wang X, Zhang H, Qin X, Xu X. Plasma selenium levels and risk of new-onset diabetes in hypertensive adults. J Trace Elem Med Biol. 2019 Jul 10. (IF:2.895)
  86. Zhang J, Cao J, Zhang Y, Li H, Zhang H, Huo Y, Li J, Liu X, Wang X, Qin X, Xu X. Baseline Plasma Zinc and Risk of First Stroke in Hypertensive Patients. Stroke. 2019 Aug 26. (IF:6.046)
  87. Zhang Y, He P, Li Y, Zhang Y, Li J, Liang M, Wang G, Tang G, Song Y, Wang B, Liu C, Liu L, Cui Y, Wang X, Huo Y, Xu X, Qin X. Positive association between baseline brachial-ankle pulse wave velocity and the risk of new-onset diabetes in hypertensive patients. Cardiovasc Diabetol. 2019 Aug 28. (IF:5.948)
  88. Huang X, Li J, Liu L, Chen G, Yi Y, Li P, Wu Y, Xu Y, Bao H, Yu L, Qin X, Zhang Y, Wang B, Li J, Fan Hou F, Huo Y, Cheng X, Spence JD. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs. Hypertens Res. 2019 Sep 27. (IF:3.217)
  89. Li Y, Spence JD, Wang X, Huo Y, Xu X, Qin X. Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial. Am J Kidney Dis. 2019 Oct 16. (IF:6.653)
  90. Xie L, Zhao BX, Luo J, Li Y, Zhu F, Li GF, He M, Wang B, Zhang H, Cai Y, Huo Y, Wang X, Hou FF, Xu X, Qin X, Nie J. A U-shaped association between serum betaine and incident risk of first ischemic stroke in hypertensive patients. Clin Nutr. 2019 Nov 15. (IF:6.402)
  91. Li Y, Zhou H, Liu M, Liang M, Wang G, Wang B, Li J, Cui Y, Song Y, Zhang Y, Xu X, Tian J, Yang M, Huo Y, Xu X, Qin X. Association of visit-to-visit variability in blood pressure and first stroke risk in hypertensive patients with chronic kidney disease. J Hypertens. 2019 Dec 12. (IF:4.209)
  92. Zhang T, Lin T, Wang Y, Wang B, Qin X, Xie F, Cui Y, Huo Y, Wang X, Zhang Z, Jiang J. Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults: Projection Based on the CSPPT. Hypertension. 2020 Feb. (IF:7.017)
  93. Qin X, Spence JD, Li J, Zhang Y, Li Y, Sun N, Liang M, Song Y, Zhang Y, Wang B, Cheng X, Zhao L, Wang X, Xu X, Huo Y. Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke. Neurology. 2020 Jan 13. (IF:8.689)
  94. Sun P, Liu L, Liu C, Zhang Y, Yang Y, Qin X, Li J, Cao J, Zhang Y, Zhou Z, Xu X, Huo Y. Carotid Intima-Media Thickness and the Risk of First Stroke in Patients With Hypertension. Stroke. 2020 Feb. (IF:6.046)
  95. Liu M, Zhang Z, Zhou C, He P, Nie J, Liang M, Liu C, Xu F, Liao G, Zhang Y, Li J, Wang B, Wang X, Huo Y, Xu X, Qin X. Relationship of body mass index and waist circumference with risk of new-onset proteinuria in hypertensive patients. J Clin Endocrinol Metab. 2020 Jan 24. (IF:5.605)